1. Genes and Genomic Entities
  2. KCTD7

KCTD7

potassium channel tetramerization domain containing 7
OMIM: 611725, Gene2Phenotype

9 panels

Panel Reviews Mode of inheritance Details
9 panels
Red KCTD7 in Glaucoma (developmental)

Level 3: Anterior segment abnormalities
Level 2: Ophthalmological disorders
Version 1.47

review Not set
Sources
  • NHS GMS
  • Emory Genetics Laboratory
Phenotypes
  • Eye Disorders
Green KCTD7 in Neuronal ceroid lipofuscinosis


Level 2: Metabolic
Version 3.2
Latest signed off version: v3.0 (30 Apr 2025)

review BIALLELIC, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • London North GLH
  • Expert Review Green
Phenotypes
  • Epilepsy, progressive myoclonic 3, with or without intracellular inclusions OMIM:611726
  • progressive myoclonic epilepsy type 3 MONDO:0012721
Red KCTD7 in Likely inborn error of metabolism


Level 2: Metabolic
Version 9.4
Latest signed off version: v9.0 (6 May 2026)

Component of the following Super Panels:

  • Childhood onset leukodystrophy
  • Hypotonic infant
  • Paediatric disorders
  • Unexplained death in infancy and sudden unexplained death in childhood

    		•  review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Other
    Phenotypes
    • Epilepsy, progressive myoclonic 3, with or without intracellular inclusions OMIM:611726
    • progressive myoclonic epilepsy type 3 MONDO:0012721
    Red KCTD7 in Fetal anomalies


    Level 2: Fetal (including NIPD)
    Version 7.10
    Latest signed off version: v7.0 (6 May 2026)

    		review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Expert Review Red
    • PAGE DD-Gene2Phenotype
    Phenotypes
    • NEURONAL CEROID LIPOFUSCINOSIS
    • PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3
    Green KCTD7 in DDG2P


    Version 7.1
    Latest signed off version: v7.0 (6 May 2026)

    Component of the following Super Panels:

  • Paediatric disorders

    		•  review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • DD-Gene2Phenotype
    • Expert Review Green
    Phenotypes
    • NEURONAL CEROID LIPOFUSCINOSIS
    • PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3 611726
    Green KCTD7 in Early onset or syndromic epilepsy


    Level 2: Neurology
    Version 9.8
    Latest signed off version: v9.0 (6 May 2026)

    Component of the following Super Panels:

  • Paediatric disorders
  • Unexplained death in infancy and sudden unexplained death in childhood

    		•  review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Wessex and West Midlands GLH
    • NHS GMS
    • NIHRBR-RD Consortium SPEED_v3.0_20170404
    • Victorian Clinical Genetics Services
    • Expert Review Green
    • Expert
    Phenotypes
    • Epilepsy, progressive myoclonic 3, with or without intracellular inclusions 611726
    Green KCTD7 in Intellectual disability


    Level 2: Developmental disorders
    Version 10.18
    Latest signed off version: v10.0 (6 May 2026)

    Component of the following Super Panels:

  • Childhood onset leukodystrophy
  • Hypotonic infant
  • Paediatric disorders

    		•  review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • Victorian Clinical Genetics Services
    • Expert Review Green
    • Radboud University Medical Center, Nijmegen
    Phenotypes
    • Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726
    • NEURONAL CEROID LIPOFUSCINOSIS
    Red KCTD7 in Retinal disorders


    Level 2: Ophthalmology
    Version 9.3
    Latest signed off version: v9.0 (6 May 2026)

    		review Not set
    Sources
    • NHS GMS
    • Expert Review Red
    Phenotypes
    • Eye Disorders
    Red KCTD7 in Structural eye disease


    Level 2: Ophthalmology
    Version 5.6
    Latest signed off version: v5.0 (6 May 2026)

    		review BIALLELIC, autosomal or pseudoautosomal
    Sources
    • NHS GMS
    • Expert Review Red
    Phenotypes
    • EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS, 611726
    • Eye Disorders